Two FMCSA committees will hold a joint meeting at the end of this month to discuss Schedule II medications’ — like painkillers and amphetamines –use by truck drivers and their impact on operators’ ability to drive.
The agency’s Motor Carrier Safety Advisory Committee (MCSAC), which will be part of the Schedule II meeting, will also be meeting on its own to discuss the agency’s upcoming rule to raise the minimum amount of liability insurance carriers and brokers must carry and subcommittee findings on FMCSA’s long-haul cross-border trucking pilot program, which concluded this month.
MCSAC and the agency’s Medical Review Board will hold its joint meeting Oct. 27 to talk Schedule II meds, and MCSAC will meet Oct. 28 to “finalize its delibrations on financial responsibility requirements for motor carriers,” according to FMCSA’s announcement. The group will also discuss findings made by its subcommittee about the cross-border trucking program.
The meetings are open to the public, and public comment will be accepted each day at the end of the meetings.
Both will be held 9 a.m. to 4:30 p.m. on their respective days, and each will be held at the Hilton Alexandria Old Town in Alexandria Va., in the Washington and Jefferson Rooms.
Written comments may be submitted, too, for consideration by the committees.
Comments will be accepted until Oct. 22, FMCSA says.